Haemonetics (HAE) Stock Soars 17% After an Analyst Rating Change
Haemonetics shares rose 17.5% as MT Newswires reported: Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating
GTA Research Desk ·
Haemonetics Corporation · $119.47 +17.46%
Haemonetics shares rose 17.5% as MT Newswires reported: Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating
4 big gainers and 6 big decliners, and the headlines behind each move.
HAE: puts took 56% of options premium; 162 institutions added shares. Here's what the data says.
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.